Pathophysiology of deep vein thrombosis

Clin Exp Med. 2023 Jul;23(3):645-654. doi: 10.1007/s10238-022-00829-w. Epub 2022 Apr 26.

Abstract

Deep venous thrombosis is a frequent, multifactorial disease and a leading cause of morbidity and mortality. Most of the time deep venous thrombosis is triggered by the interaction between acquired risk factors, such as hip fracture, pregnancy, and immobility, and hereditary risk factors such as thrombophilias. The mechanisms underlying deep venous thrombosis are not fully elucidated; however, in recent years, important advances have shed light on the role of venous flow, endothelium, platelets, leukocytes, and the interaction between inflammation and hemostasis. It has been described that the alteration of venous blood flow produces endothelial activation, favoring the adhesion of platelets and leukocytes, which, through tissue factor expression and neutrophil extracellular traps formation, contribute to the activation of coagulation, trapping more cells, such as red blood cells. Thus, the concerted interaction of these phenomena allows the formation and growth of the thrombus. In this work, the main mechanisms involved in the pathophysiology of deep vein thrombosis will be described.

Keywords: Coagulation; DVT; Endothelium; Leukocyte; Platelet; Venous valves.

Publication types

  • Review

MeSH terms

  • Blood Coagulation
  • Blood Platelets
  • Humans
  • Inflammation
  • Leukocytes
  • Venous Thrombosis* / metabolism